title: The insulin-like growth factor axis and collagen turnover during prednisolone treatment.
abstract: Serum concentrations of insulin-like growth factor I (IGF-I) and insulin-like growth factor binding protein 3 (IGFBP-3), the carboxyterminal propeptide of type I collagen (PICP), the carboxyterminal pyridinoline crosslinked telopeptide of type I collagen (ICTP), and the aminoterminal propeptide of type III procollagen (PIIINP) were studied in 10 prepubertal children with asthma (mean age 9.0 years). The children were treated with 2.5 and 5.0 mg/day prednisolone in a randomised double blind crossover trial with run in, treatment, and washout periods of two weeks. No statistically significant effects on serum concentrations of IGF-I and IGFBP-3 were found. Dose related reductions of PICP, ICTP, and PIIINP were observed: the mean (SEM) reduction in PICP was 33.4 (26.3) and 68.4 (20.6) micrograms/l, in ICTP 2.5 (0.5) and 2.9 (0.6) micrograms/l, and in PIIINP 2.1 (0.7) and 3.1 (1.8) micrograms/l during the 2.5 and 5.0 mg prednisolone periods respectively. Short term treatment with low daily doses of prednisolone is associated with suppression of serum markers of type I and III collagen turnover in children with asthma. Intermediate and long term effects remain to be studied.
authors.affiliation: Department of Paediatrics, Kolding Hospital, Denmark.
authors.forename: O D
authors.initials: OD
authors.lastname: Wolthers
authors.forename: A
authors.initials: A
authors.lastname: Juul
authors.forename: M
authors.initials: M
authors.lastname: Hansen
authors.forename: J
authors.initials: J
authors.lastname: Müller
authors.forename: S
authors.initials: S
authors.lastname: Pedersen
mesh_terms: D001249:Asthma / Q000097:blood* / Q000188:drug therapy; D002352:Carrier Proteins / Q000097:blood / Q000187:drug effects*; D002648:Child; D003094:Collagen / Q000187:drug effects* / Q000378:metabolism; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006131:Growth Inhibitors / Q000097:blood*; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins; D007334:Insulin-Like Growth Factor I / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D011239:Prednisolone / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D002352:Carrier Proteins; D006131:Growth Inhibitors; D018969:Insulin-Like Growth Factor Binding Proteins; D007334:Insulin-Like Growth Factor I; D003094:Collagen; D011239:Prednisolone